ATE533499T1 - Bacillus smithii-stamm tbmi12 mscl p737 und verwendung von endosporen davon als probiotisches mittel oder nahrungszusatz - Google Patents

Bacillus smithii-stamm tbmi12 mscl p737 und verwendung von endosporen davon als probiotisches mittel oder nahrungszusatz

Info

Publication number
ATE533499T1
ATE533499T1 AT07817985T AT07817985T ATE533499T1 AT E533499 T1 ATE533499 T1 AT E533499T1 AT 07817985 T AT07817985 T AT 07817985T AT 07817985 T AT07817985 T AT 07817985T AT E533499 T1 ATE533499 T1 AT E533499T1
Authority
AT
Austria
Prior art keywords
endospores
food additive
bacillus smithii
strain
probiotic agent
Prior art date
Application number
AT07817985T
Other languages
English (en)
Inventor
Eerik Joegi
Allan Nurk
Indrek Suitso
Ene Talpsep
Paul Naaber
Krista Laivukene
Original Assignee
Tartu Uelikool University Of Tartu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tartu Uelikool University Of Tartu filed Critical Tartu Uelikool University Of Tartu
Application granted granted Critical
Publication of ATE533499T1 publication Critical patent/ATE533499T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
AT07817985T 2006-12-08 2007-10-08 Bacillus smithii-stamm tbmi12 mscl p737 und verwendung von endosporen davon als probiotisches mittel oder nahrungszusatz ATE533499T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EEP200600038A EE05459B1 (et) 2006-12-08 2006-12-08 Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon
PCT/EE2007/000021 WO2008067827A1 (en) 2006-12-08 2007-10-08 Bacillus smithii strain tbmi12 mscl p737 and use of endospores thereof as a probiotic or a food supplement

Publications (1)

Publication Number Publication Date
ATE533499T1 true ATE533499T1 (de) 2011-12-15

Family

ID=38921740

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07817985T ATE533499T1 (de) 2006-12-08 2007-10-08 Bacillus smithii-stamm tbmi12 mscl p737 und verwendung von endosporen davon als probiotisches mittel oder nahrungszusatz

Country Status (8)

Country Link
EP (1) EP2101796B1 (de)
AT (1) ATE533499T1 (de)
DK (1) DK2101796T3 (de)
EE (1) EE05459B1 (de)
ES (1) ES2374082T3 (de)
RU (1) RU2439145C2 (de)
UA (1) UA99450C2 (de)
WO (1) WO2008067827A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2509149C1 (ru) * 2012-08-31 2014-03-10 Общество с ограниченной ответственностью "НОВА" ШТАММ Bacillus subtilis subsp. Subtilis ВКМ В-2711D, ОБЛАДАЮЩИЙ ВЫРАЖЕННЫМ АНТАГОНИЗМОМ ПО ОТНОШЕНИЮ К Escherichia coli, Salmonella typhi, Staphylococcus aureus, Listeria monocytogenes И РЕЗИСТЕНТНОСТЬЮ К СТРЕПТОМИЦИНУ И ТЕТРАЦИКЛИНУ
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
CA3212215A1 (en) 2012-11-23 2014-05-30 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
CA2899925A1 (en) 2013-02-04 2014-08-07 Seres Therapeutics, Inc. Compositions and methods for inhibition of pathogenic bacterial growth
HK1218560A1 (zh) 2013-02-04 2017-02-24 Seres Therapeutics, Inc. 组成与方法
EP2967077A4 (de) 2013-03-15 2016-09-14 Seres Therapeutics Inc Netzwerkbasierte mikrobielle zusammensetzungen und verfahren
EP3074027B1 (de) 2013-11-25 2024-12-18 Seres Therapeutics, Inc. Synergistische bakterielle zusammensetzungen und verfahren zur herstellung und verwendung davon
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
RS57471B1 (sr) 2015-12-17 2018-09-28 Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerzitet U Beogradu Nova probiotička starter kultura za humanu i animalnu primenu
EP3668527A1 (de) 2017-08-14 2020-06-24 Seres Therapeutics, Inc. Zusammensetzungen und verfahren zur behandlung von cholestase
JP2021501185A (ja) 2017-10-30 2021-01-14 セレス セラピューティクス インコーポレイテッド 抗生物質耐性を処置するための組成物及び方法
CN114410514B (zh) * 2021-12-31 2024-04-02 上海新溢生物科技工程研究中心(有限合伙) 斯密氏芽孢杆菌及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1262927B (it) * 1992-01-14 1996-07-22 Consiglio Nazionale Ricerche Batteri sporgenti e loro impiego come probiotici
ITMI20021800A1 (it) * 2002-08-07 2004-02-08 Proge Farm Srl Composizione farmaceutica e/o nutraceutica comprendente una associazione di microorganismi probiotici non sporigeni e spore di bacillus subtilis e/o clausii.
CN101076585A (zh) * 2003-08-14 2007-11-21 生物平衡公司 细菌株系、包括该细菌株系的组合物和其益生菌用途

Also Published As

Publication number Publication date
ES2374082T3 (es) 2012-02-13
EP2101796A1 (de) 2009-09-23
DK2101796T3 (da) 2012-02-13
EP2101796B1 (de) 2011-11-16
RU2439145C2 (ru) 2012-01-10
EE05459B1 (et) 2011-08-15
EE200600038A (et) 2008-08-15
UA99450C2 (ru) 2012-08-27
WO2008067827A1 (en) 2008-06-12
RU2009126450A (ru) 2011-01-20

Similar Documents

Publication Publication Date Title
ATE533499T1 (de) Bacillus smithii-stamm tbmi12 mscl p737 und verwendung von endosporen davon als probiotisches mittel oder nahrungszusatz
Jabalameli et al. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients
Tajeddin et al. The role of the intensive care unit environment and health-care workers in the transmission of bacteria associated with hospital acquired infections
Anderson et al. Enterococcus faecalis from food, clinical specimens, and oral sites: prevalence of virulence factors in association with biofilm formation
MY151204A (en) Lactobacillus plantarum and uses thereof
Pieniz et al. Evaluation of resistance genes and virulence factors in a food isolated Enterococcus durans with potential probiotic effect
NZ593708A (en) Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
EP4257194A3 (de) Verwendung von mikrobiellen gemeinschaften für human- und tiergesundheit
BRPI1010637A2 (pt) suplementos nutricionais orais compreendendo probióticos
GB2465051A (en) Probiotic bifidobacterium strains
MX2009012694A (es) Composicones y metodos utiles para modular la inmunidad, mejorar la eficacia de vacunas, disminuir la morbilidad asociada con infecciones cronicas por fhv-1, y prevenir o tratar la conjuntivitis.
ATE440132T1 (de) Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger
ATE302265T1 (de) Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon
MY146595A (en) Probiotic bifidobacterium strains
ZA200803819B (en) Probiotic Enterococci for improved immunity
DK1874917T3 (da) Probiotisk sammensætning, der er egnet til dyr
ATE498325T1 (de) Verwendung von probiotika und ballaststoffen bei diarrhö
NZ612294A (en) Novel bacterium and extracts of said bacterium and the use of same in dermatology
TR201901771T4 (tr) Memelilerde kemik kaybının önlenmesi veya tedavi edilmesinde kullanıma yönelik lactobacillus reuteri ATCC PTA 6475.
NO20055653L (no) Forbedring av helsen og/eller naeringsstatusen hos et akvarisk dyr ved hjelp av Bacillus licheniformis
WO2005112976A3 (en) Probiotic compounds from lactobacillus gg and uses therefor
WO2007090123A3 (en) Mgra is a redox regulator of antibiotic sensitivity and virulence
WO2014081980A3 (en) Mutant ngal proteins and uses thereof
James et al. Exploring the probiotic potential of B. cereus and B. velezensis associated with mangrove sediments in aquaculture
EA200701730A1 (ru) Бактериоцины и новые бактериальные штаммы